6/9 Indonesia’s PT Norma and Taiwan’s ACE Biotek Collaborate to Develop Indonesian Hospital Market

Caption: Eva Hayati, Operational Director of PT Norma and Steve Hsu, President of ACE Biotek
From left to right: Arrahman Oktavianda, Engineer Manager of PT Norma, Rudi Antoni, President Director of RAFA Topaz Utama, Steve Hsu, President of ACE Biotek, and Eva Hayati, Operational Director of PT Norma

[Taipei, Taiwan / Jakarta, Indonesia – June 9, 2023] Advanced ACEBIOTEK CO., LTD. (ACE Biotek) and PT NORMA Diagnostika Indonesia (PT Norma) are delighted to announce the signing of a Memorandum of Understanding (MOU) on June 9, 2023. This collaboration aims to jointly develop and explore opportunities in the Indonesian hospital market. Representatives in the signing ceremony are Steve Hsu, President of ACE Biotek, and Eva Hayati, Operational Director of PT Norma. Notably, the contract signing uses the Uniiform smart pen, symbolizing the integration of innovative technology into the partnership.

PT Norma, a leading provider of information systems (HIS) for Indonesian hospitals, is partnering with ACE Biotek, a specialist in developing smart hospital technologies. The collaboration will focus on integrating ACE Biotek’s Uniiform Smart Handwriting System (UniiForm) software into PT Norma’s HIS system. This integration will enable the introduction of advanced healthcare solutions in Indonesian hospitals, streamlining medical staff efforts and enhancing the quality of care. Uniiform preserves user behavior and synchronously uploads handwriting records in real-time, facilitating a paperless environment and enabling AI-driven extensive data analysis and early disease diagnosis.

The partnership between ACE Biotek and PT Norma originated from a visit where PT Norma witnessed ACE Biotek’s technological achievements. Recognizing the market potential and aligning with the Southeast Asian EMR trend, PT Norma identified Uniiform as the cutting-edge product that complements its vision for the Indonesian healthcare sector. This MOU signifies a significant stride towards advancing healthcare technology in Indonesia. By combining expertise, the companies aim to contribute to meet patient care enhancement and smart hospital development.

Expressing his enthusiasm for the partnership, Mr. Steve Hsu, President of ACE Biotek, stated, “We are excited to collaborate with PT Norma to introduce our Uniiform Smart Handwriting System to Indonesian hospitals. The MOU represents a significant step towards enhancing healthcare technology in Indonesia and improving patient care.”

Ms. Eva Hayati, Operational Director of PT Norma, shared similar sentiments, remarking, “We believe that the Uniiform Smart Handwriting System has immense potential in the Indonesian market. By integrating Uniiform into our HIS system, we aim to offer an advanced system that aligns with the EMR trends. We will expand the user reference site to multiple hospitals across Indonesia.”

For media inquiries, please contact:

Advanced ACE Biotek Co., Ltd.:

Jenny Lin

Address: No. 66, Shengyi 2nd Rd., Zhubei City, Hsinchu County 302, Taiwan (Hsinchu Biomedical Science Park)

Phone: +886-3-5500909#3407

E-mail: jenny_lin@acebiotek.com

Website: https://www.acebiotek.com/

Facebook: https://www.facebook.com/Acebiotek/

LinkedIn: https://www.linkedin.com/company/30620922/admin/

PT NORMA Diagnostika Indonesia:

Arrahman Oktavianda

Address: Jl. KRT Radjiman Widyodiningrat No A23 Cakung, Jakarta Timur, 13930

Phone: +6282317171799

E-mail: oktavianda@normaindonesia.co.id

Website: https://www.normaindonesia.co.id/

About ACE Biotek

Established in 2000, ACE Group has grown for more than 20 years across wireless and healthcare industries. Originally, ACE Group formed ACE Solution as its first foray to focus on wireless communication, networking hardware, and customized system integration projects. Driven by President Steve’s vision to improve healthcare quality, he built the ACE Biotek building from the ground up and officially founded ACE Biotek in 2018. ACE Biotek integrates the past 20 years of industrial experience and knowledge to solve unmet clinical needs. In order to achieve the early diagnosis of diseases, we have developed smart medical solutions regarding imaging algorithms, cloud computing, artificial intelligence, and terahertz technology so far. Long term, ACE Biotek will expand globally to serve as a platform to cultivate talents and support tech companies to transform into Medtech.

About PT Norma

Established in 2014, PT. Norma has grown for almost than 10 years in the In Vitro Diagnostics and IT Healthcare Solution business across Indonesia. From its first foundation, PT. Norma Diagnostika Indonesia is focused on distribution of In Vitro Diagnostics medical devices and its consumables as well. In 2017, PT. Norma Diagnostika Indonesia start cooperation with Hospital Information System provider based in South Korea, and nowadays PT. Norma focusing on distributing IT Healthcare Solution with additional cooperation with PACS from South Korea and Laboratory Information Management System from India. In long term, PT. Norma will expand its business to become One-stop Solution for IT Healthcare in Indonesia.

5/30 ACE Biotek and TWCA (TAIWAN-CA Inc.) Sign Memorandum of Understanding to expand collaboration on Uniipen Smart Pen Technology and Electronic Signature Applications

Caption: Steve Hsu, President of ACE Biotek (left), and Stephen Lee, Chairman of TWCA (right), representing the signing of the ceremony.

ACE Biotek, known for its successful implementation of smart hospital solutions, officially signed a cooperation memorandum with TWCA on May 30, 2023. The collaboration aims to enhance the partnership between Uniipen smart pen technology and electronic signature applications, working together to create mutual value. Stephen Lee, Chairman of TWCA, and Steve Hsu, President of ACE Biotek, represented the signing ceremony.

TWCA is a leading global provider of network certification services dedicated to driving digital transformation and providing secure and reliable authentication solutions. Its innovative technology and excellent service quality have earned complete customer trust. As the pioneer from 3C to the medical industry, ACE Biotek combines its expertise in wireless communication hardware and software integration with AI platform technology to develop smart medical data upload solutions. These solutions are applied to electronic medical record digitization and instrument data acquisition and analysis, with successful collaborations and implementations in representative domestic hospitals. The signing of this MOU aims to combine the technical strengths of both parties by integrating electronic signature or encryption technology into smart handwriting applications.

Steve Hsu, President of ACE Biotek, stated that the signing of this cooperation memorandum represents an innovative strategy. In addition to being used for EMR, Uniiform smart handwriting system is also utilized with the Data Stream Gateway (DS), which retrieves and integrates device data. By combining it with TWCA’s electronic signature technology in the future, the applications can be expanded from healthcare to other industries. Integration with companies in the science park makes it possible to introduce the technology into more underserved areas.

Stephen Lee, Chairman of TWCA, also emphasized that this collaboration will focus on the innovative integration of electronic signatures with Uniipen smart pens. It represents the perfect combination of both companies’ core competencies and business focus. Through cooperation with ACE Biotek, the goal is to provide customers with a superior, convenient, and secure experience in handwritten electronic forms. The success of this collaboration is expected to bring continued growth and mutual value to both parties.

6/29 5G x智慧醫療跨域研討會 5G x Smart Health Cross-Border Seminar

5G及B5G具有廣連結、大頻寬、低延遲等特性,結合AIoT等先進科技為智慧醫療應用,帶來新市場及醫護人員的簡便。後疫情時代除了加速工控技術與產業轉型,即時性、高速穩定、超高頻寬,進而促進遠距醫療、智慧醫療,蓬勃帶動數位化服務創新、數據傳輸之資安保護為重要關鍵。

筑波集團在無線通訊測試應用累積20年,擁有5G/B5G、WiFi 6/6E等實務技術,從3C到3醫,整合AI技術開發智慧醫療數據方案,應用於各醫療院所的實務經驗。昇頻公司專注賦能5G智慧連結及智慧互聯網垂直應用,本次共同攜手展開5G x智慧醫療跨域研討會,並於現場展示實務應用成果。誠摰邀請業界先進至報名網站參與,名額有限。

超強跨域卡司:昇頻PROSCEND, 辰隆科技TRANSNET, 英柏得EMBESTOR

聚焦分享:

  • 辰隆科技: 賦能智慧5G專網 創造數位轉型新紀元
  • 昇頻:5G x Edge AI運算生智 前進智慧應用新藍海
  • 筑波科技:資訊安全關鍵因素於車用通訊系統
  • 英柏得: 前進AI智慧醫療的專用暨安全性強化之資料存儲裝置與應用系統
  • 醫院資訊系統/平台之介紹與跳戰
  • 筑波科技:5G NR / WiFi 7 /NB-IoT 最佳無線通訊測試方案
  • 筑波科技:AIoT醫療應用-手術麻醉與生理資訊的上傳系統

活動日期:  2023年06月29日(四) PM12:30 – PM17:00

活動地點:  諾貝爾講堂 – 新竹縣竹北市生醫二路66號 筑波醫電大樓1F (新竹生醫園區)

報名方式:  03-5500909 ext. 3407林小姐 / 3800 蔡小姐  service@acesolution.com.tw

線上報名:  https://register.acesolution.com.tw/20230629_5GxSmartHealth_Seminar